Here's the latest variant picture with a global scope, to mid-June.
The LP.8.1.*, NB.1.8.1 "Nimbus" and XFG.* "Stratus" variants are battling for dominance in an unclear picture.
XFG.* "Stratus" seemed to have the best underlying momentum, until recently when samples from the US became less dominant.
@godotengine Did you have to use google forms for this when there are open source alternatives, google cooperates with the genocidal Israeli government https://theintercept.com/2024/12/02/google-project-nimbus-ai-israel/ #palestine #BDS #israel #google #nimbus #godot
Here's the latest variant picture for the "Global - Other" countries, to early June.
The NB.1.8.1 "Nimbus" variant rose as high as 61%, but fell back in later samples to 26%.
XFG.* "Stratus" grew strongly to 49%.
This perspective excludes all the high-volume countries and regions that I routinely report on: Australia, NZ, Europe, Canada and the US. The remaining countries are aggregated into this report.
Here's the latest variant picture for Europe (excluding the UK), to early June.
The LP.8.1.* variant continued to dominate, but fell to 33% frequency.
The XFG.* "Stratus" variant grew strongly to 28%.
The NB.1.8.1 "Nimbus" variant has not been as successful, at 17%.
Here's the latest variant picture for the United Kingdom, to mid-June.
The LP.8.1.* variant fell to around 30% frequency.
The XFG.* "Stratus" variant grew strongly to be just dominant at 31%.
Growth of the NB.1.8.1 "Nimbus" accelerated to 29%.
A double-wave seems very likely in the UK. This scenario raises the risk of rapid reinfections, for those relying on immunity from a recent infection.
Here's the latest variant picture for the United States, to early June.
The XFG.* "Stratus" variant grew strongly to dominance at 41%, while LP.8.1.* fell to 25%.
The NB.1.8.1 "Nimbus" variant grew steadily, to 20%.
Here's the latest variant picture for Canada, to mid-June.
The NB.1.8.1 "Nimbus" variant grew strongly to dominance at around 36%. LP.8.1.* fell to around 28%.
The XFG.* "Stratus" variant is also quite prevalent at around 19%. This is a novel scenario – until now I’ve only seen one or the other growing strongly in each country or region.
A double-wave seems very likely in Canada. This scenario raises the risk of rapid reinfections, for those relying on immunity from a recent infection.
Here's the latest variant picture for New Zealand, to mid-June.
The NB.1.8.1 "Nimbus" variant remained dominant, finishing at around 56% frequency.
The XFG.* "Stratus" variant is the likely next challenger as it has just become dominant globally. In NZ, XFG.* finished at 5%.
Here's the latest variant picture for Australia, to early June.
The NB.1.8.1 "Nimbus" variant has continued to dominate at 51%, but growth has flatlined.
The XFG.* "Stratus" variant is the likely next challenger as it has just become dominant globally. In Australia, XFG.* is still only at 7%.
#COVID19 #Australia #NB_1_8_1 #Nimbus #XFG #Stratus @auscovid19
🧵
Here's the latest variant picture with a global scope, to early June.
The LP.8.1.*, NB.1.8.1 "Nimbus" and XFG.* "Stratus" variants are battling for dominance in an unclear picture.
XFG.* "Stratus" seemed to have the best underlying momentum, until recently when samples from the US became less dominant.
Nueva variante del coronavirus: ¿qué se sabe de Nimbus y cómo las vacunas pueden protegernos? | vía #UChileRadio
#coronavirus #guillermozepeda #nimbus #oms #organizaciónmundialdelasalud #vacunas
"Une énième vague de Covid est en cours. Après un hiver relativement calme, sans vague épidémique malgré l’appellation totalement fausse de «virus saisonnier» accolée par les agences sanitaires françaises à Sars-CoV-2, le virus circule à nouveau activement parmi nous en Europe, après des signaux d’alerte depuis plusieurs semaines en Asie, où il est encore surveillé… Le ministère de Santé publique thaïlandais avait ainsi dénombré plus de 53 000 cas de Covid entre le 18 et le 24 mai 2025, dont une dizaine de morts, relançant pendant un moment la discussion sur la fermeture des écoles, jugée inutile du fait des mesures de testing et d’isolement des malades. En France, le recueil des eaux usées a montré une remontée de la présence du virus ; les cabinets médicaux et les plateformes de téléconsultation voient ressurgir plus souvent des patients présentant des symptômes évocateurs du Covid, dont l’agueusie (perte du goût) et l’anosmie (perte de l’odorat). Le variant circulant actuellement, NB.1.8.1, surnommé «Nimbus», semble se distinguer par un symptôme particulièrement douloureux, une sensation de lame de rasoir dans la gorge, autrement dit… un symptôme particulièrement banal dans les angines, aussi appelées, pour être plus précis, des amygdalites."
https://www.liberation.fr/societe/sante/nb181-le-nouveau-variant-du-covid-qui-sevit-dans-lindifference-generale-20250621_CFCK744HSJEELLPIRLO6BMUVKI/
#covid19 #pandémie #CovidIsNotOver #Nimbus #NB181 #santé #santéPublique #vaccin
Here's the latest variant picture for the "Global - Other" countries, to early June.
The NB.1.8.1 "Nimbus" variant rose as high as 57%, but fell back in later samples to 29%.
The XFG.* "Stratus" variant is challenging, growing to 27%.
The odd-looking bump in the JN.1.* + FLiRT group is down to a relatively large batch of samples collected across 3 days in late May, from Kazakhstan. The LF.7.1.3 sub-variant was dominant.
That will likely be smoothed out as more data arrives from other countries.
This perspective excludes all the high-volume countries and regions that I routinely report on: Australia, NZ, Europe, Canada and the US. The remaining countries are aggregated into this report.
Here's the latest variant picture for Europe (excluding the UK), to early June.
The LP.8.1.* variant continued to dominate, but fell to 36% frequency.
The XFG.* "Stratus" variant grew strongly to 28%.
The NB.1.8.1 "Nimbus" variant has not been as successful, at 14%.
Here's the latest variant picture for the United Kingdom, to early June.
The LP.8.1.* variant was still dominant, but fell to around 38% frequency.
The XFG.* "Stratus" variant grew strongly to 34%, and looks like the next challenger.
Here's the latest variant picture for the United States, to early June.
The XFG.* "Stratus" variant grew strongly to 35%, while LP.8.1.* fell to 28%.
The NB.1.8.1 "Nimbus" variant grew strongly, to 24%.
Here's the latest variant picture for Canada, to early June.
The LP.1.8.* variant remained dominant, but fell to finish at around 38% frequency.
Both the NB.1.8.1 "Nimbus" and XFG.* "Stratus" variants grew strongly to around 25%. This is a novel scenario – until now I’ve only seen one or the other growing strongly in each country or region.
A double-wave seems very likely in Canada. This scenario raises the risk of rapid reinfections, for those relying on immunity from a recent infection.
Here's the latest variant picture for New Zealand, to early June.
The NB.1.8.1 "Nimbus" variant remained dominant, finishing at around 52% frequency.
The XFG.* "Stratus" variant is the likely next challenger as it has just become dominant globally. In NZ, XFG.* grew to 7%.
A double-wave seems increasingly likely in NZ, as we saw in late 2023 to early 2024. The EG.5.* "Eris" wave was built upon by JN.1.* "Pirola". This scenario raises the risk of rapid reinfections, for those relying on immunity from a recent infection.
Here's the latest variant picture for Australia, to early June.
The NB.1.8.1 "Nimbus" variant has continued to dominate at 53%, but growth appears to be slowing.
The XFG.* "Stratus" variant is the likely next challenger as it has just become dominant globally. In Australia, XFG.* doubled since last week, to 9%.
Another double-wave seems increasingly likely in Australia, as we saw in late 2023 to early 2024. The EG.5.* "Eris" wave was built upon by JN.1.* "Pirola". This scenario raises the risk of rapid reinfections, for those relying on immunity from a recent infection.
#COVID19 #Australia #NB_1_8_1 #Nimbus #XFG #Stratus @auscovid19
🧵
Here's the latest variant picture with a global scope, to early June.
The NB.1.8.1 "Nimbus" variant has been struggling lately, at around 25%.
Growth of the XFG.* "Stratus" variant accelerated to 28%, and it is now dominant.
The odd-looking bump in the JN.1.* + FLiRT group is down to a relatively large batch of samples collected across 3 days in late May, from Kazakhstan. The LF.7.1.3 sub-variant was dominant.
That will likely be smoothed out as more data arrives from other countries.
